Himalaya Drug Company, a Bangalore-based herbal healthcare company, will double its turnover to Rs. 500 crore in the next couple of years and expand its operations to Egypt. "A high rate of growth in the ayurvedic growth segment is expected to provide a demand boost that will propel growth. The international market is also taking ayurveda in a big way. Lastly, we will introduce a number of new products that will directly add to our bottom line," President and Chief Executive Officer of the company, Ravi Prasad said.

(From left) Dr. S.K. Mitra, Executive director,
Himalaya Drug company, Ava Mukherjee,
brand ambassador, and Ravi Prasad,
President & CEO, Himalaya Drug Company,
at the Launch of 'Himalaya Chyavanaprasha'
in Kolkata on Thursday.